Jann G. P. Tijssen

Jann G. P. Tijssen's AcademicInfluence.com Rankings

Jann G. P. Tijssen

Philosophy

#4764

World Rank

#7400

Historical Rank

Logic

#2156

World Rank

#3084

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jann G. P. Tijssen's Degrees

PhD Medical Sciences University of Amsterdam
Masters Biomedical Sciences University of Amsterdam

Why Is Jann G. P. Tijssen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jann G. P. Tijssen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Duodenal infusion of donor feces for recurrent Clostridium difficile. (2013) (3035)
Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. (2002) (1594)
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. (2003) (1310)
Prognostic Association of Depression Following Myocardial Infarction With Mortality and Cardiovascular Events: A Meta-analysis (2004) (1049)
Lenient versus strict rate control in patients with atrial fibrillation. (2010) (856)
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. (2015) (788)
Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. (2000) (726)
Colchicine in Patients with Chronic Coronary Disease. (2020) (625)
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective, randomized trial (2002) (620)
Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. (2014) (561)
Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. (2010) (544)
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH). (2008) (542)
Early invasive versus selectively invasive management for acute coronary syndromes. (2005) (542)
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. (2011) (540)
Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction. (2017) (534)
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study. (2004) (467)
Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. (2006) (456)
The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. (2005) (414)
Outcome parameters for trials in atrial fibrillation: executive summary. (2007) (413)
Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial (2019) (401)
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones (1997) (385)
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? (2008) (362)
Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. (2012) (350)
To operate or not on elderly patients with aortic stenosis: the decision and its consequences (1999) (344)
Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. (1993) (341)
Risk stratification for sudden cardiac death: current status and challenges for the future† (2014) (336)
Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease (2006) (325)
Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity (2014) (314)
Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis. (2001) (310)
Effect of early intravenous heparin on coronary patency, infarct size, and bleeding complications after alteplase thrombolysis: results of a randomised double blind European Cooperative Study Group trial. (1992) (310)
Transthoracic Versus Transhiatal Resection for Carcinoma of the Esophagus: A Meta-Analysis (2001) (306)
Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial. (2016) (283)
Aortic stiffness and diameter predict progressive aortic dilatation in patients with Marfan syndrome. (2004) (274)
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. (2019) (272)
Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. (2007) (269)
Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos (2000) (264)
Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. (2005) (253)
Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel (2014) (247)
Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors. (1995) (245)
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. (2011) (237)
Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary intervention. (2009) (229)
Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. (2006) (229)
Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. (1997) (225)
Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. a retrospective study of 2300 consecutive patients with venous thromboembolism (2005) (215)
Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands. (1989) (213)
Placebos and placebo effects in medicine: historical overview (1999) (196)
Bioresorbable Scaffolds versus Metallic Stents in Routine PCI (2017) (194)
Hyperemic Stenosis Resistance Index for Evaluation of Functional Coronary Lesion Severity (2002) (191)
The recurrence pattern of esophageal carcinoma after transhiatal resection. (2000) (190)
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. (1996) (186)
Magnetic resonance angiography for the diagnosis of renal artery stenosis: a meta-analysis. (2002) (186)
Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. (1999) (186)
QT interval variables from 24 hour electrocardiography and the two year risk of sudden death. (1993) (179)
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study. (2005) (176)
Randomized Trial Comparing Same-Day Discharge With Overnight Hospital Stay After Percutaneous Coronary Intervention: Results of the Elective PCI in Outpatient Study (EPOS) (2007) (175)
Evaluating the systemic right ventricle by CMR: the importance of consistent and reproducible delineation of the cavity (2008) (174)
Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients. (1995) (174)
Survival and complication free survival in Marfan’s syndrome: implications of current guidelines (1999) (173)
Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. (1993) (166)
Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. (2005) (162)
Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics (2007) (162)
Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. (2019) (160)
Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group. (1993) (157)
A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy. (2001) (154)
Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution: a quantitative angiographic study in 1,445 successfully dilated lesions. (1992) (153)
START Trial: A Pilot Study on STimulation of ARTeriogenesis Using Subcutaneous Application of Granulocyte-Macrophage Colony-Stimulating Factor as a New Treatment for Peripheral Vascular Disease (2005) (149)
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? (1986) (147)
5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. (2010) (147)
Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study (2007) (146)
Persistent precordial “hyperacute” T-waves signify proximal left anterior descending artery occlusion (2009) (145)
Impact of multivessel coronary disease on long-term mortality in patients with ST-elevation myocardial infarction is due to the presence of a chronic total occlusion. (2006) (145)
Presence of Older Thrombus Is an Independent Predictor of Long-Term Mortality in Patients With ST-Elevation Myocardial Infarction Treated With Thrombus Aspiration During Primary Percutaneous Coronary Intervention (2008) (144)
Intervention research. (1995) (144)
Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. (2014) (142)
Abnormalities in liver function and coagulation profile following the Fontan procedure (1999) (142)
Placebo effect in the treatment of duodenal ulcer. (1999) (140)
Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. (1996) (138)
Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry. (2015) (136)
Influence of Percutaneous Coronary Intervention on Coronary Microvascular Resistance Index (2005) (136)
Complete versus culprit vessel percutaneous coronary intervention in multivessel disease: a randomized comparison. (2004) (135)
Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis. (2002) (135)
Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. (1991) (134)
Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. (2014) (132)
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Ele (2011) (132)
Exercise-related out-of-hospital cardiac arrest in the general population: incidence and prognosis. (2013) (132)
Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. (2012) (132)
Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design. (2002) (129)
Relative Risk Analysis of Angiographic Predictors of Restenosis Within the Coronary Wallstent (1991) (129)
The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study. (2011) (128)
The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: The Academic Medical Center intensive care unit experience* (2011) (128)
Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial. (2002) (124)
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study (2009) (122)
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial. (2009) (121)
International Study on Microcirculatory Shock Occurrence in Acutely Ill Patients* (2015) (120)
Caregiver burden in partners of Heart Failure patients; limited influence of disease severity (2007) (118)
Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial. (2016) (117)
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial (2013) (117)
Beyond the root: dilatation of the distal aorta in Marfan’s syndrome (2006) (117)
Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism. (2016) (117)
Effect of multivessel coronary disease with or without concurrent chronic total occlusion on one-year mortality in patients treated with primary percutaneous coronary intervention for cardiogenic shock. (2010) (116)
Fractional flow reserve, absolute and relative coronary blood flow velocity reserve in relation to the results of technetium-99m sestamibi single-photon emission computed tomography in patients with two-vessel coronary artery disease. (2001) (116)
Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease (1996) (114)
The effect of thyroxine treatment started in the neonatal period on development and growth of two-year-old Down syndrome children: a randomized clinical trial. (2005) (114)
Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T. (2003) (112)
Evaluation of Ketanserin in the Prevention of Restenosis After Percutaneous Transluminal Coronary Angioplasty A Multicenter Randomized Double‐Blind Placebo‐Controlled Trial (1993) (111)
Thyroid and adrenal axis in major depression: a controlled study in outpatients. (2005) (111)
A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ÉLAN-HF Score (2013) (110)
Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. (2005) (109)
Diagnostic Accuracy of Combined Intracoronary Pressure and Flow Velocity Information During Baseline Conditions: Adenosine-Free Assessment of Functional Coronary Lesion Severity (2012) (109)
Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. (2004) (108)
Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials (2011) (107)
Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors. A randomized study. (1996) (107)
Early or Delayed Cardioversion in Recent‐Onset Atrial Fibrillation (2019) (106)
Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. (2008) (106)
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction. (2011) (106)
Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. (2011) (105)
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study (2019) (103)
Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction (2006) (101)
Diagnostic performance of angiography-derived fractional flow reserve: a systematic review and Bayesian meta-analysis (2018) (100)
Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease. (2002) (100)
Long-Term Cardiovascular Mortality After Procedure-Related or Spontaneous Myocardial Infarction in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: A Collaborative Analysis of Individual Patient Data From the FRISC II, ICTUS, and RITA-3 Trials (FIR) (2012) (100)
Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment (2014) (99)
Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3'-triiodothyronine therapy. (2005) (97)
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study (2017) (96)
Effects of mechanical left ventricular unloading by impella on left ventricular dynamics in high‐risk and primary percutaneous coronary intervention patients (2010) (95)
Left ventricular thrombus formation after acute myocardial infarction as assessed by cardiovascular magnetic resonance imaging. (2012) (94)
The prognostic value of bleeding academic research consortium (BARC)-defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occlu (2014) (94)
Subdural hematoma and oral anticoagulant therapy. (1982) (92)
Comorbidity, Hospitalization, and Medication Use and Their Influence on Mental and Motor Development of Young Infants With Down Syndrome (2006) (91)
Impact of strut thickness on late luminal loss after coronary artery stent placement. (2004) (91)
Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. (2011) (90)
Comparison of balloon-expandable vs. self-expandable valves in patients undergoing transfemoral transcatheter aortic valve implantation: from the CENTER-collaboration (2019) (90)
A Randomized Comparison of Paclitaxel-Eluting Balloon Versus Everolimus-Eluting Stent for the Treatment of Any In-Stent Restenosis: The DARE Trial. (2017) (90)
The prognostic value of combined intracoronary pressure and blood flow velocity measurements after deferral of percutaneous coronary intervention (2008) (90)
The impact of multivessel disease with and without a co‐existing chronic total occlusion on short‐ and long‐term mortality in ST‐elevation myocardial infarction patients with and without cardiogenic shock (2013) (89)
Nutritional status over time in hemodialysis and peritoneal dialysis. (2001) (89)
Impact of Pretreatment With Clopidogrel on Initial Patency and Outcome in Patients Treated With Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Systematic Review (2008) (87)
Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials (2012) (87)
Randomised controlled trial of brief neonatal exposure to cows’ milk on the development of atopy (1998) (87)
Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF PCI trial (2018) (86)
Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. (2008) (85)
Inpatient treatment of children and adolescents with severe obesity in the Netherlands: a randomized clinical trial. (2014) (85)
NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?) (2018) (81)
Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. (2009) (81)
Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial. (2017) (80)
Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia. (2017) (80)
Diagnostic and Prognostic Implications of Coronary Flow Capacity: A Comprehensive Cross-Modality Physiological Concept in Ischemic Heart Disease. (2015) (80)
Impact of Coronary Microvascular Function on Long-term Cardiac Mortality in Patients With Acute ST-Segment–Elevation Myocardial Infarction (2013) (79)
The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial. (2016) (77)
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study. (2004) (76)
Troponin T and myoglobin at admission: value of early diagnosis of acute myocardial infarction. (1994) (75)
Indicators of prognosis after transhiatal esophageal resection without thoracotomy for cancer. (2002) (75)
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II. (2006) (73)
Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure (2008) (72)
Primary percutaneous coronary intervention for ST elevation myocardial infarction in octogenarians: trends and outcomes (2009) (72)
Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score. (2008) (71)
Safety of low dose heparin in elective coronary angioplasty. (1997) (71)
Recombinant Tissue‐Type Plasminogen Activator and Immediate Angioplasty in Acute Myocardial Infarction: One‐Year Follow‐up (1992) (70)
Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. (2008) (69)
Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy (2015) (69)
Head-to-head comparison of basal stenosis resistance index, instantaneous wave-free ratio, and fractional flow reserve: diagnostic accuracy for stenosis-specific myocardial ischaemia. (2015) (69)
Digoxin in patients with permanent atrial fibrillation: data from the RACE II study. (2014) (69)
Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial. (2004) (69)
Evaluation of toe pressure and transcutaneous oxygen measurements in management of chronic critical leg ischemia: a diagnostic randomized clinical trial. (2003) (68)
Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: insights from the IMAGINE trial (2011) (67)
Impaired Coronary Autoregulation Is Associated With Long-term Fatal Events in Patients With Stable Coronary Artery Disease (2013) (67)
Variability in treatment advice for elderly patients with aortic stenosis: a nationwide survey in the Netherlands (2001) (66)
Routine use of the transradial approach in primary percutaneous coronary intervention: procedural aspects and outcomes in 2209 patients treated in a single high-volume centre (2011) (65)
Assessment of "silent" restenosis and long-term follow-up after successful angioplasty in single vessel coronary artery disease: the value of quantitative exercise electrocardiography and quantitative coronary angiography. (1990) (65)
Gender differences in long‐term outcome after primary percutaneous intervention for ST‐segment elevation myocardial infarction (2013) (65)
Predictors and Permanency of Cardiac Conduction Disorders and Necessity of Pacing after Transcatheter Aortic Valve Implantation (2014) (65)
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology. (2016) (65)
The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. (2002) (64)
Time course of microvascular resistance of the infarct and noninfarct coronary artery following an anterior wall acute myocardial infarction. (2006) (63)
Repaired and open atrial septal defects type II in adulthood: an epidemiological study of a large European cohort. (2008) (63)
Clinical results after coronary stenting with the Genous™ Bio-engineered R stent™: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. (2011) (63)
Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin. (2002) (63)
Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (2010) (62)
Triiodothyronine addition to paroxetine in the treatment of major depressive disorder. (2004) (61)
Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes (2008) (61)
Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. (2021) (61)
Right ventricular dysfunction is an independent predictor for mortality in ST‐elevation myocardial infarction patients presenting with cardiogenic shock on admission (2010) (61)
Randomized comparison of primary percutaneous coronary intervention with combined proximal embolic protection and thrombus aspiration versus primary percutaneous coronary intervention alone in ST-segment elevation myocardial infarction: the PREPARE (PRoximal Embolic Protection in Acute myocardial in (2009) (61)
Retardation and arrest of progression or regression of coronary artery disease: a review. (1993) (60)
Relation between exercise-induced hypertension and sustained hypertension in adult patients after successful repair of aortic coarctation (2004) (59)
Histopathological Features of Aspirated Thrombi after Primary Percutaneous Coronary Intervention in Patients with ST-Elevation Myocardial Infarction (2009) (58)
Triage of patients for short term observation after elective coronary angioplasty (2000) (58)
Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. (2012) (57)
1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. (2011) (56)
Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. (2009) (56)
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial (2008) (56)
Disparity between dobutamine stress and physical exercise magnetic resonance imaging in patients with an intra-atrial correction for transposition of the great arteries. (2005) (55)
Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement. (2004) (54)
C-Reactive protein and cardiac troponin T in risk stratification: differences in optimal timing of tests early after the onset of chest pain. (2000) (53)
Pathological Q waves in myocardial infarction in patients treated by primary PCI. (2013) (53)
Morbidity and mortality in patients waiting for coronary artery bypass surgery. (2001) (53)
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results (2008) (53)
Frequency of coronary ostial aneurysms after aortic root surgery in patients with the Marfan syndrome. (2002) (53)
Nurse-led vs. usual-care for atrial fibrillation. (2019) (53)
Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure. (2002) (53)
Infective Endocarditis After Melody Valve Implantation in the Pulmonary Position: A Systematic Review (2018) (52)
Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial. (2006) (52)
Prevalence and impact of a chronic total occlusion in a non-infarct-related artery on long-term mortality in diabetic patients with ST elevation myocardial infarction (2010) (52)
Trisomy 21 causes persistent congenital hypothyroidism presumably of thyroidal origin. (2006) (51)
Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience (2018) (50)
Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T. (2009) (50)
The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics. (2019) (50)
Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study. (2014) (50)
Two year follow-up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study. (2008) (50)
A comparison of methods of analysing exercise tests for diagnosis of coronary artery disease. (1989) (50)
Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke: From the CENTER-Collaboration (2019) (50)
Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study. (2011) (49)
Assessment of Prevalence of Persons with Down Syndrome: A Theory-Based Demographic Model. (2011) (49)
The Objective Burden in Partners of Heart Failure Patients; Development and Initial Validation of the Dutch Objective Burden Inventory (2008) (49)
A systematic review and meta-analysis on primary percutaneous coronary intervention of an unprotected left main coronary artery culprit lesion in the setting of acute myocardial infarction. (2013) (49)
C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: data from the prospective PREVEND cohort. (2008) (49)
Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study (2011) (49)
Involvement of stress in the pathogenesis of autoimmune thyroid disease: A prospective study (2012) (48)
N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. (2007) (48)
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC). (2018) (48)
Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction (2018) (48)
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation). (2013) (48)
Competing Risk of Cardiac Status and Renal Function During Hospitalization for Acute Decompensated Heart Failure. (2015) (48)
Clinical parameters associated with collateral development in patients with chronic total coronary occlusion (2013) (47)
Radiation exposure during percutaneous coronary interventions and coronary angiograms performed by the radial compared with the femoral route. (2012) (47)
Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk (2015) (47)
Prediction of surgical strategy in mitral valve regurgitation based on echocardiography. Interuniversity Cardiology Institute of The Netherlands. (1997) (47)
Prediction of spinal epidural metastases. (2000) (47)
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study (2019) (46)
In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. (2007) (46)
NT-proBNP-Guided Therapy in Acute Decompensated Heart Failure: The PRIMA II Randomized Controlled Trial (2017) (45)
Determinants for early mortality in patients awaiting coronary artery bypass graft surgery: a case-control study. (1992) (45)
Distal Embolization of Hydrophilic-Coating Material From Coronary Guidewires After Percutaneous Coronary Interventions (2015) (45)
Which elderly patients with severe aortic stenosis benefit from surgical treatment? An aid to clinical decision making. (2004) (45)
D-dimer levels predict ischemic and hemorrhagic outcomes after acute myocardial infarction: a HORIZONS-AMI biomarker substudy (2013) (44)
1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry. (2016) (44)
Outcome prediction in coronary artery bypass grafting and valve surgery in the Netherlands: development of the Amphiascore and its comparison with the Euroscore. (2003) (43)
Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias. (2008) (43)
C-reactive protein and coronary events following percutaneous coronary angioplasty (2003) (42)
Quantitative echocardiographic analysis of global and regional left ventricular function: a problem revisited. (1990) (42)
Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure (2013) (41)
The influence of gender on short- and long-term outcome after primary PCI and delivered medical care for ST-segment elevation myocardial infarction. (2010) (41)
Mortality in adult congenital heart disease: are national registries reliable for cause of death? (2011) (41)
Initiation of health-behaviour change among employees participating in a web-based health risk assessment with tailored feedback (2011) (41)
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study Group. (1991) (41)
Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris. (2009) (41)
Acute left ventricular dynamic effects of primary percutaneous coronary intervention from occlusion to reperfusion. (2009) (40)
Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial (2017) (40)
Is endoscopic balloon dilation for removal of bile duct stones associated with an increased risk for pancreatitis or a higher rate of hyperamylasemia? (2001) (40)
A pilot study of coronary angioplasty in outpatients. (1994) (39)
Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study. (2012) (39)
Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification (2017) (39)
Gender Differences in Transfemoral Transcatheter Aortic Valve Replacement. (2019) (39)
Prevalence of left and balanced coronary arterial dominance decreases with increasing age of patients at autopsy. A postmortem coronary angiograms study. (2013) (39)
Two hour ambulation after coronary angioplasty and stenting with 6 F guiding catheters and low dose heparin (1999) (38)
Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study. (1992) (38)
Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study in ST-segment elevation myocardial infarction and comprehensive meta-analysis. (2014) (38)
Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. (2007) (38)
Iloprost (ZK 36374) enhances recovery of regional myocardial function during reperfusion after coronary artery occlusion in the pig (1986) (37)
Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study (2013) (37)
Two‐year follow‐up of the genous™ endothelial progenitor cell capturing stent versus the taxus liberté stent in patients with De Novo coronary artery lesions with a high‐risk of restenosis (2011) (37)
Plasma N-terminal pro-B-type natriuretic peptide for prediction of death or nonfatal myocardial infarction following percutaneous coronary intervention. (2004) (37)
Clinical and angiographic predictors and prognostic value of failed thrombus aspiration in primary percutaneous coronary intervention. (2011) (36)
Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results. (1998) (36)
Amsterdam Investigator-initiateD Absorb strategy all-comers trial (AIDA trial): a clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent (2014) (36)
Distinguishing the right coronary artery from the left circumflex coronary artery as the infarct-related artery in patients undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction. (2009) (35)
Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. (2014) (35)
Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. (2006) (35)
Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-PRoBNP target on the reduction of readmIssion and Mortality rAtes. (2014) (34)
Comparison of aortic elasticity in patients with the marfan syndrome with and without aortic root replacement. (2003) (34)
Association between complex coronary artery stenosis and unstable angina and the extent of plaque inflammation. (2003) (34)
Contribution of creatine kinase MB mass concentration at admission to early diagnosis of acute myocardial infarction. (1994) (33)
Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies. (2003) (33)
Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial. (2017) (33)
Excimer laser angioplasty versus balloon angioplasty in functional and total coronary occlusions. (1996) (33)
Towards minimally invasiveness: transcatheter aortic valve implantation under local analgesia exclusively. (2014) (33)
Impella CP Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock : The IMPRESS trial (2016) (33)
Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients. (2008) (33)
Infarct size and left ventricular function in the PRoximal Embolic Protection in Acute myocardial infarction and Resolution of ST-segment Elevation (PREPARE) trial: ancillary cardiovascular magnetic resonance study (2009) (32)
The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial). (2017) (32)
Clinical outcome of single versus sequential grafts in coronary bypass operations at ten years' follow-up. (1991) (32)
Inter-core lab variability in analyzing quantitative coronary angiography for bifurcation lesions: a post-hoc analysis of a randomized trial. (2015) (31)
The role of endoscopic Doppler US in patients with peptic ulcer bleeding. (2003) (31)
Smoking and its effects on mortality in adults with congenital heart disease. (2008) (31)
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions. (2013) (31)
Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study. (2015) (31)
Stress is not associated with thyroid peroxidase autoantibodies in euthyroid women (2005) (31)
Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus. (2014) (31)
How critical is frame selection in quantitative coronary angiographic studies? (1989) (31)
Historical developments of atrial septal defect closure devices: what we learn from the past (2016) (31)
Mitral regurgitation is an independent predictor of 1-year mortality in ST-elevation myocardial infarction patients presenting in cardiogenic shock on admission. (2010) (30)
Recurrent unstable angina after directional coronary atherectomy is related to the extent of initial coronary plaque inflammation. (2001) (30)
Transmyocardial revascularization using an XeCl excimer laser: results of a randomized trial. (2004) (30)
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary int (2010) (30)
Predictors of outcome in patients undergoing MitraClip implantation: An aid to improve patient selection. (2015) (30)
Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease. (2014) (29)
Long-term safety and sustained left ventricular recovery: long-term results of percutaneous left ventricular support with Impella LP2.5 in ST-elevation myocardial infarction. (2011) (29)
High-sensitivity troponin T is associated with poor outcome in adults with pulmonary arterial hypertension due to congenital heart disease. (2013) (29)
Comparison of models for quantitative left ventricular wall motion analysis from two-dimensional echocardiograms during acute myocardial infarction. (1993) (29)
Coronary angiography after cardiac arrest: Rationale and design of the COACT trial. (2016) (29)
Energy conservation by nisoldipine in ischaemic heart (1984) (29)
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies. (2017) (29)
Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive (2012) (29)
The Effect of Adding Ticagrelor to Standard Aspirin on Saphenous Vein Graft Patency in Patients Undergoing Coronary Artery Bypass Grafting (POPular CABG): A Randomized, Double-Blind, Placebo-Controlled Trial. (2020) (28)
Primary percutaneous coronary intervention for patients with acute ST elevation myocardial infarction with and without diabetes mellitus (2005) (28)
Mortality risk of untreated myosin-binding protein C-related hypertrophic cardiomyopathy: insight into the natural history. (2011) (28)
One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry. (2015) (28)
Timing of Mortality After Severe Bleeding and Recurrent Myocardial Infarction in Patients With ST-Segment–Elevation Myocardial Infarction (2013) (28)
Validity of conjoint analysis to study clinical decision making in elderly patients with aortic stenosis. (2004) (28)
Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease. (2014) (28)
Histopathology of aspirated thrombus and its association with ST‐segment recovery in patients undergoing primary percutaneous coronary intervention with routine thrombus aspiration (2011) (27)
Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies. (2013) (27)
Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study. (2014) (27)
Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction (1989) (27)
Pulsed-wave transmitral Doppler do not diagnose moderate acute rejection after heart transplantation. (1993) (27)
Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS) (2020) (27)
Clinical characteristics of persistent lone atrial fibrillation in the RACE study. (2004) (26)
Carotid intima–media thickness in post-coarctectomy patients with exercise induced hypertension (2005) (26)
The comparative value of exercise echocardiography and 99m Tc MIBI single photon emission computed tomography in the diagnosis and localization of myocardial ischaemia. (1991) (26)
Recurrent myocardial infarction after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2014) (26)
Intracoronary pressure and flow velocity for hemodynamic evaluation of coronary stenoses (2003) (26)
Improved diagnostic stratification of digitised Barrett's oesophagus biopsies by p53 immunohistochemical staining (2018) (25)
Impact of experimentally-induced expectancy on the analgesic efficacy of tramadol in chronic pain patients: a 2 x 2 factorial, randomized, placebo-controlled, double-blind trial. (2001) (25)
Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience. (2013) (25)
Thyrotropin, but not a polymorphism in type II deiodinase, predicts response to paroxetine in major depression. (2006) (24)
Intracoronary hemodynamic effects of pressure-controlled intermittent coronary sinus occlusion (PICSO): results from the First-In-Man Prepare PICSO Study. (2012) (24)
Changes in left ventricular function and wall thickness in heart transplant recipients and their relation to acute rejection: an assessment by digitised M mode echocardiography (1992) (24)
Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock (2012) (24)
Prediction of 1-Year Mortality With Different Measures of ST-Segment Recovery in All-Comers After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction (2010) (24)
Long-term prognostic value of CFVR and FFR versus perfusion scintigraphy in patients with multivessel disease (2007) (24)
C-reactive protein and coronary events following percutaneous coronary angioplasty. (2003) (24)
Antiplatelet therapy: new foundations for optimal treatment decisions. (1999) (24)
Value of systolic pulmonary venous flow reversal and color Doppler jet measurements assessed with transesophageal echocardiography in recognizing severe pure mitral regurgitation. (1996) (24)
Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis. (2015) (23)
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI. (2018) (23)
Adherence to guidelines in the clinical care for adults with congenital heart disease: the Euro Heart Survey on adult congenital heart disease. (2006) (23)
Participation in a workplace web-based health risk assessment program. (2011) (23)
What happens to patients starting dialysis in the Netherlands? (2001) (23)
Multivariate risk factor analysis of clinical outcome 15 years after venous coronary artery bypass graft surgery. (1995) (23)
Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials). (2012) (23)
Contribution of the 24 hour electrocardiogram to the prediction of sudden coronary death. (1993) (23)
Number-needed-to-treat and placebo-controlled trials (1998) (23)
The Systematic COronary Risk Evaluation (SCORE) in a large UK population: 10-year follow-up in the EPIC-Norfolk prospective population study (2015) (23)
Transfemoral TAVR in Nonagenarians: From the CENTER Collaboration. (2019) (23)
Prognostic value of predischarge 12 lead electrocardiogram after myocardial infarction compared with other routine clinical variables. (1987) (22)
Cardiovascular disease risk and secondary prevention of cardiovascular disease among patients with low health literacy (2017) (22)
Comparison of transthoracic and transesophageal echocardiography with surgical findings in mitral regurgitation. The ESMIR Research Group. (1996) (22)
Alcohol Consumption as a Risk Factor for Autoimmune Thyroid Disease: A Prospective Study (2012) (22)
The prognostic value of markers of inflammation in patients with troponin T-negative chest pain before discharge from the emergency department. (2003) (22)
Increased hyperaemic coronary microvascular resistance adds to the presence of myocardial ischaemia. (2014) (22)
Fluvastatin in Acute Myocardial Infarction: Effects on Early and Late Ischemia and Events: the FLORIDA Trial (2000) (22)
Right ventricular systolic function in patients undergoing transcatheter aortic valve implantation: A systematic review and meta-analysis. (2018) (22)
Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI. (2019) (21)
Predictors and prognostic consequence of gastrointestinal bleeding in patients with ST-segment elevation myocardial infarction. (2015) (21)
Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease. (2017) (21)
Patient, lesion, and procedural variables as risk factors for luminal re- narrowing after successful coronary angioplasty: A quantitative analysis in 653 patients with 778 lesions (1993) (21)
One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent. (2017) (21)
Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial. (2015) (21)
Angiographic assessment of aortic regurgitation by video‐densitometry in the setting of TAVI: Echocardiographic and clinical correlates (2017) (21)
RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists (2009) (20)
Guideline-defined futility or patient-reported outcomes to assess treatment success after TAVI: what to use? Results from a prospective cohort study with long-term follow-up (2018) (20)
ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial. (2007) (20)
Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery (2017) (20)
Effect ofMetformin on Left Ventricular Function After AcuteMyocardial Infarction in PatientsWithout Diabetes The GIPS-III Randomized Clinical Trial (2014) (20)
Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension. (1996) (20)
Long term outcome after mononuclear bone marrow or peripheral blood cells infusion after myocardial infarction (2014) (20)
A simplified and reproducible method to size the mitral annulus: implications for transcatheter mitral valve replacement (2016) (19)
Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study. (2014) (19)
Design and rationale of the TRI-stent adjudication study (TRIAS) program. (2009) (19)
Non-ST-segment elevation myocardial infarction: revascularization for everyone? (2012) (19)
Echocardiographic and angiographic assessment of paravalvular regurgitation after TAVI: optimizing inter-technique reproducibility. (2016) (19)
1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration. (2018) (19)
Long-acting coronary vasodilatory action of the molsidomine metabolite Sin 1: a quantitative angiographic study. (1987) (19)
Early onset of endothelial cell proliferation in coronary thrombi of patients with an acute myocardial infarction: implications for plaque healing (2012) (19)
Deep vein thrombosis of the upper extremity: intra- and interobserver study of digital subtraction venography (2003) (18)
Proximal embolic protection with aspiration in percutaneous coronary intervention using the Proxis device. (2007) (18)
Clinical and angiographic predictors of ST-segment recovery after primary percutaneous coronary intervention. (2010) (18)
Comparison of valve performance of the mechanically expanding Lotus and the balloon-expanded SAPIEN3 transcatheter heart valves: an observational study with independent core laboratory analysis (2018) (18)
Cardiac denervation after clinical transmyocardial laser revascularization: short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence. (2004) (18)
Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study. (2019) (18)
Effects of a nurse-coordinated prevention programme on health-related quality of life and depression in patients with an acute coronary syndrome: results from the RESPONSE randomised controlled trial (2016) (18)
Feasibility and applicability of computer‐assisted myocardial blush quantification after primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction (2010) (18)
Clinical events following excimer laser angioplasty or balloon angioplasty for complex coronary lesions: subanalysis of a randomised trial (1998) (18)
Dynamics in N-terminal pro-brain natriuretic peptide concentration in patients with non-ST-elevation acute coronary syndrome. (2005) (18)
Total burden of intraplaque hemorrhage in coronary arteries relates to the use of coumarin-type anticoagulants but not platelet aggregation inhibitors (2014) (18)
Adjunctive thrombus aspiration versus conventional percutaneous coronary intervention in ST‐elevation myocardial infarction (2013) (17)
Revascularization strategies in patients with diabetes. (2013) (17)
Determinants of survival after surgery for mitral valve regurgitation in patients with and without coronary artery disease. (1990) (17)
Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention. (2010) (17)
Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and R (1993) (17)
Clinical outcomes after percutaneous or surgical revascularisation of unprotected left main coronary artery-related acute myocardial infarction: a single-centre experience (2013) (17)
Impact of percutaneous coronary intervention timing on 5-year outcome in patients with non-ST-segment elevation acute coronary syndromes. The ‘wait a day’ approach might be safer (2016) (16)
One‐year clinical outcome in an unselected patient population treated with the Genous™ endothelial progenitor cell capturing stent (2011) (16)
Treatment of coronary bifurcation lesions with the Absorb bioresorbable vascular scaffold in combination with the Tryton dedicated coronary bifurcation stent: evaluation using two- and three-dimensional optical coherence tomography. (2015) (16)
18F-Fluoride Positron Emission Tomographic Imaging of Penile Arteries and Erectile Dysfunction. (2019) (16)
Thrombus aspiration alone during primary percutanous coronary intervention as definitive treatment in acute ST‐elevation myocardial infarction (2012) (16)
A pattern of disperse plaque microcalcifications identifies a subset of plaques with high inflammatory burden in patients with acute myocardial infarction. (2011) (16)
Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registry. (2011) (16)
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial. (2018) (16)
Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions (2012) (16)
Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium: a cardiac MR imaging study. (2014) (16)
Long-term left ventricular remodelling after revascularisation for ST-segment elevation myocardial infarction as assessed by cardiac magnetic resonance imaging (2017) (16)
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: Insights from the randomized GLOBAL LEADERS trial. (2019) (16)
Optical coherence tomography versus intravascular ultrasound in the evaluation of observer variability and reliability in the assessment of stent deployment: The OCTIVUS study (2015) (16)
Generation of platelet-derived microparticles in patients undergoing cardiac surgery is not affected by complement activation. (2003) (16)
Relationship between in vitro lipopolysaccharide-induced cytokine response in whole blood, angiographic in-stent restenosis, and toll-like receptor 4 gene polymorphisms. (2005) (15)
Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial (2020) (15)
Long‐term outcomes and cost effectiveness of high‐dose dexamethasone for cardiac surgery: a randomised trial (2017) (15)
One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent. (2010) (15)
Prognostic value of myocardial perfusion scintigraphy in type 2 diabetic patients with mild, stable angina pectoris (2009) (15)
Subgroup analyses in trial reports comparing percutaneous coronary intervention with coronary artery bypass surgery. (2013) (15)
Impact of Coronary Remodeling on Fractional Flow Reserve. (2018) (15)
First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting. (2016) (15)
Prognostic value of post-procedural aPTT in patients with ST-elevation myocardial infarction treated with primary PCI (2013) (15)
Cell Saver device efficiently removes cell-derived microparticles during cardiac surgery. (2007) (15)
Retransfusion of pericardial blood does not trigger systemic coagulation during cardiopulmonary bypass. (2007) (14)
No survival benefit of extended transthoracic resection over limited transhiatal resection for adenocarcinoma of the mid/distal esophagus and gastric cardia: results of a randomized study. (2002) (14)
Duration of dual antiplatelet therapy and outcomes after coronary stenting with the genous™ bio‐engineered R stent™ in patients from the e‐healing registry (2012) (14)
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial. (2019) (14)
Basal stenosis resistance index derived from simultaneous pressure and flow velocity measurements. (2016) (14)
Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome (2017) (14)
Two-year clinical outcomes of patients treated with the dual-therapy stent in a 1000 patient all-comers registry (2017) (14)
Relationship between biomarkers and subsequent clinical and angiographic restenosis after paclitaxel-eluting stents for treatment of STEMI: a HORIZONS-AMI substudy (2011) (13)
Three-year clinical follow-up of an unselected patient population treated with the genous endothelial progenitor cell capturing stent. (2011) (13)
Excimer laser coronary angioplasty in The Netherlands: preamble for a randomized study. (1993) (13)
Variation in phenotypic appearance of Graves' disease: effect of genetic anticipation and duration of complaints. (2009) (13)
Creatinine clearance is independently associated with one year mortality in a primary PCI cohort with cardiogenic shock (2009) (13)
Genotypes in relation to phenotypic appearance and exposure to environmental factors in Graves' hyperthyroidism. (2012) (13)
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions. (2015) (12)
Optical coherence tomography findings: insights from the "randomised multicentre trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting stents with durable polymer in chronic total occlusions" (PRISON IV) trial. (2017) (12)
Percutaneous implantation of the CoreValve aortic valve prosthesis in patients at high risk or rejected for surgical valve replacement: Clinical evaluation and feasibility of the procedure in the first 30 patients in the AMC-UvA. (2010) (12)
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria. (2016) (12)
Colchicine in Patients With Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome. (2021) (12)
A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study (2012) (12)
Clinical outcomes after percutaneous coronary intervention with the COMBO stent versus Resolute Integrity and PROMUS Element stents: a propensity-matched analysis. (2017) (12)
Coronary hemodynamics of stent implantation after suboptimal and optimal balloon angioplasty. (2002) (11)
Percutaneous coronary intervention for non ST-elevation acute coronary syndromes: which, when and how? (2011) (11)
Impact of early, late, and no ST-segment resolution measured by continuous ST Holter monitoring on left ventricular ejection fraction and infarct size as determined by cardiovascular magnetic resonance imaging. (2011) (11)
Representativeness and response rates from the Domestic/International Gastroenterology Surveillance Study (DIGEST). (1999) (11)
Clinical characteristics, cardiac events and coronary angiographic findings in the prospective PREVEND cohort: an observational study (2007) (11)
Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting. (1994) (11)
Impact of Potentially Malignant Incidental Findings by Computed Tomographic Angiography on Long-Term Survival After Transcatheter Aortic Valve Implantation. (2017) (11)
Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry (2012) (11)
Duodenal mucosal resurfacing combined with GLP-1RA to discontinue insulin in type 2 diabetes: a feasibility study. (2020) (11)
Short- and long-term prognostic value of the TIMI risk score after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2013) (11)
Gender difference in the prognostic value of estimated glomerular filtration rate at admission in ST-segment elevation myocardial infarction: a prospective cohort study (2012) (11)
Adhesion of thrombotic components to the surface of a clinically used oxygenator is not affected by Trillium coating (2006) (11)
Early identification of patients at risk for significant left ventricular dilation one year after myocardial infarction. (1995) (11)
[Annual chest X-ray in patients after treatment for laryngeal or oral cancer: only a limited number of second primary lung cancers detected]. (1999) (11)
Clinical outcomes after final kissing balloon inflation compared with no final kissing balloon inflation in bifurcation lesions treated with a dedicated coronary bifurcation stent (2014) (11)
Older coronary thrombus is an independent predictor of 1‐year mortality in acute myocardial infarction (2016) (10)
Erratum: Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents. J Am Coll Cardiol Intv 2011;4:97481 (2011) (10)
Comparison of twelve-month outcomes after percutanous coronary intervention with everolimus-eluting versus zotarolimus-eluting or sirolimus-eluting stents from the PROENCY (PROmus ENdeavor CYpher) registry. (2012) (10)
Demystifying the New Statistical Recommendations: The Use and Reporting of p Values. (2016) (10)
Cardiac troponin release following hybrid coronary revascularization versus off-pump coronary artery bypass surgery. (2014) (10)
Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent: an e-HEALING worldwide registry substudy (2012) (10)
Role of plaque inflammation in acute and recurrent coronary syndromes. (2004) (10)
Effect of beta-blockers on the relation between QT-interval and heart rate in exercise ECG. (1987) (10)
Coronary Stenting With the Genous(TM) Bio-Engineered R Stent(TM) in Elderly Patients (2011) (10)
Usefulness of multiplane transesophageal echocardiography to improve the assessment of severity of mitral regurgitation. (1996) (10)
Procedural Outcome and Midterm Survival of Lower Risk Transfemoral Transcatheter Aortic Valve Implantation Patients Treated With the SAPIEN XT or SAPIEN 3 Device. (2018) (10)
Circadian and weekly variation and the influence of environmental variables in acute myocardial infarction (2012) (10)
Cardiac 123I-MIBG imaging and clinical variables in risk stratification in patients with heart failure treated with beta blockers (2002) (10)
Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: The SPIRIT II Trial (2009) (10)
Twelve-month clinical outcomes after coronary stenting with the Genous Bio-engineered R Stent in patients with a bifurcation lesion: from the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) registry (2012) (10)
Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis: The COMPARE-ABSORB Randomized Clinical Trial. (2020) (10)
Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial. (2017) (10)
Antiplatelet therapy: views from the experts. (1999) (10)
Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease (2020) (10)
Plasma glucose and not hemoglobin or renal function predicts mortality in patients with STEMI complicated with cardiogenic shock (2010) (9)
Molsidomine, an effective long-acting anti-anginal drug. (1983) (9)
Recovery of microcirculation after intracoronary infusion of bone marrow mononuclear cells or peripheral blood mononuclear cells in patients treated by primary percutaneous coronary intervention the Doppler substudy of the Hebe trial. (2011) (9)
Multiple biomarkers at admission are associated with angiographic, electrocardiographic, and imaging cardiovascular mechanistic markers of outcomes in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction. (2012) (9)
Predictive models for thoracic aorta surgery. Is the Euroscore the optimal risk model in the Netherlands? (2005) (9)
Is there a need to control the placebo in placebo controlled trials? (1997) (9)
Nurses' perspectives on nurse-coordinated prevention programmes in secondary prevention of cardiovascular disease: a pilot survey (2015) (9)
Prospective evaluation of where reperfusion ventricular arrhythmia "bursts" fit into optimal reperfusion in STEMI. (2015) (9)
Influence of chronic kidney disease on anticoagulation levels and bleeding after primary percutaneous coronary intervention in patients treated with unfractionated heparin (2015) (9)
1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents. (2020) (9)
The diagnostic randomized clinical trial is the best solution for management issues in critical limb ischemia. (2004) (9)
Performance of gastrointestinal pathologists within a national digital review panel for Barrett’s oesophagus in the Netherlands: results of 80 prospective biopsy reviews (2020) (9)
Rate control versus electrical cardioversion for persistent atrial fibrillation in patients with heart failure : results of the RACE study (2001) (9)
Prevalence of myocardial ischaemia as assessed with myocardial perfusion scintigraphy in patients with diabetes mellitus type 2 and mild anginal symptoms (2006) (9)
Predictors of residual tricuspid regurgitation after percutaneous closure of atrial septal defect (2018) (9)
Visual estimation versus different quantitative coronary angiography methods to assess lesion severity in bifurcation lesions (2018) (9)
Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention (2010) (9)
Long-term ischaemic and bleeding outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction in the elderly (2015) (9)
Coronary microcirculatory dysfunction is associated with left ventricular dysfunction during follow-up after STEMI (2013) (9)
Impact of collateralisation to a concomitant chronic total occlusion in patients with ST-elevation myocardial infarction: a subanalysis of the EXPLORE randomised controlled trial (2018) (9)
Ticagrelor Monotherapy Beyond One Month after PCI in ACS or Stable CAD in Elderly Patients Aged Above 75 Years: a Prespecified Analysis of the Randomized GLOBAL LEADERS Trial. (2019) (9)
Recovery and prognostic value of myocardial strain in ST-segment elevation myocardial infarction patients with a concurrent chronic total occlusion (2019) (8)
Early ST-segment recovery after primary percutaneous coronary intervention accurately predicts long-term prognosis after acute myocardial infarction. (2010) (8)
Percutaneous coronary intervention for acute coronary syndrome due to graft failure (2014) (8)
Ventricular arrhythmia burst is an independent indicator of larger infarct size even in optimal reperfusion in STEMI. (2016) (8)
Microvascular dysfunction following ST-elevation myocardial infarction and its recovery over time. (2017) (8)
Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation - Data from RACE 3. (2020) (8)
Impact of Ticagrelor Monotherapy on Two-Year Clinical Outcomes in Patients with Long Stenting: A Post Hoc Analysis of the Global Leaders Trial. (2020) (8)
Early Treatment of Unstable Angina with Nifedipine and Metoprolol‐The HINT Trial (1988) (8)
Lack of long‐term clinical benefit of thrombus aspiration during primary percutaneous coronary intervention with paclitaxel‐eluting stents or bare‐metal stents: Post‐hoc analysis of the PASSION‐trial (2012) (8)
Intermediate lesions : Intracoronary flow assessment versus Tc-99m-MIBI SPECT (ILIAS study); A Dutch multicenter study. (2000) (8)
Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis (2020) (8)
Five‐year follow‐up of the endothelial progenitor cell capturing stent versus the paxlitaxel‐eluting stent in de novo coronary lesions with a high risk of coronary restenosis (2018) (7)
Late catch-up in lumen diameter at five-year angiography in MACE-free patients treated with sirolimus-eluting stents in the Primary Stenting of Totally Occluded Native Coronary Arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatm (2013) (7)
A nationwide survey on perception, experience, and expectations of hybrid coronary revascularization among top-ranked US hospitals. (2015) (7)
Three‐year clinical outcomes after dual‐therapy COMBO stent placement: Insights from the REMEDEE registry (2019) (7)
A granular approach to improve reproducibility of the echocardiographic assessment of paravalvular regurgitation after TAVI (2016) (7)
Significant intimal hyperplasia regression between 6 and 18 months following Genous™ endothelial progenitor cell capturing stent placement. (2011) (7)
Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study (2021) (7)
Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. (2019) (7)
An immediate or early invasive strategy in non-ST-elevation acute coronary syndrome: the OPTIMA-2 randomized controlled trial. (2021) (7)
BASAL STENOSIS RESISTANCE INDEX AND INSTANTANEOUS WAVE–FREE RATIO HAVE THE SAME DIAGNOSTIC PERFORMANCE AS FRACTIONAL FLOW RESERVE TO DETECT MYOCARDIAL ISCHEMIA USING MYOCARDIAL PERFUSION IMAGING (2013) (7)
Proximal embolic protection in patients undergoing primary angioplasty for acute myocardial infarction (PREPARE): core lab adjudicated angiographic outcomes of a randomised controlled trial (2010) (7)
Preventive angioplasty in myocardial infarction. (2014) (7)
Multiple biomarkers for the prediction of short and long-term mortality after ST-segment elevation myocardial infarction: the Amsterdam Groningen collaboration (2012) (7)
3-Year Clinical Outcomes of the PRISON-IV Trial: Ultrathin Struts Versus Conventional Drug-Eluting Stents in Total Coronary Occlusions. (2019) (7)
A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria (2011) (7)
Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention. (2013) (6)
Percutaneous treatment of bifurcated lesions: a simple approach with a single bare metal R stent provides favourable long term clinical results. (2006) (6)
Do NSAIDs Actually Protect Against Myocardial Infarction and Death? (2009) (6)
Absorb bioresorbable scaffold versus Xience metallic stent for prevention of restenosis following percutaneous coronary intervention in patients at high risk of restenosis: Rationale and design of the COMPARE ABSORB trial. (2019) (6)
Computer‐assisted quantification of myocardial reperfusion after primary percutaneous coronary intervention predicts functional and contrast‐enhanced cardiovascular magnetic resonance outcomes in patients with ST‐segment elevation myocardial infarction (2011) (6)
Acute haemodynamic effects of accelerated idioventricular rhythm in primary percutaneous coronary intervention. (2011) (6)
Cardiac complications in type 2 diabetic patients with mild anginal symptoms and documented reversible myocardial perfusion defects: Results of the MERIDIAN trial. (2006) (6)
Side branch healing patterns of the Tryton dedicated bifurcation stent: a 1-year optical coherence tomography follow-up study (2014) (6)
Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry. (2017) (6)
Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventions. (2016) (6)
Comparative Methodological Assessment of the Randomized GLOBAL LEADERS Trial Using Total Ischemic and Bleeding Events (2020) (6)
The value of N-terminal proB-type natriuretic peptide for early identification of myocardial infarction in patients with high-risk non-ST-elevation acute coronary syndromes (2011) (6)
Reperfusion ventricular arrhythmia bursts identify larger infarct size in spite of optimal epicardial and microvascular reperfusion using cardiac magnetic resonance imaging (2018) (6)
ST‐Segment Resolution Prior to Primary Percutaneous Coronary Intervention Is a Poor Indicator of Coronary Artery Patency in Patients with Acute Myocardial Infarction (2010) (6)
Clinical Implications of Distal Vessel Stenosis After Successful Coronary Chronic Total Occlusion Recanalization. (2018) (6)
First report on long‐term clinical results after treatment of coronary bifurcation lesions with the Tryton dedicated bifurcation stent (2014) (6)
Relationship between biomarkers and subsequent bleeding risk in ST-segment elevation myocardial infarction patients treated with paclitaxel-eluting stents: a HORIZONS-AMI substudy (2013) (6)
NT‐ProBNP serum levels reflect severity and extent of ischemia in patients admitted with non‐ST‐elevation acute coronary syndrome (2006) (6)
Relationship between cardiac metaiodobenzylguanidine uptake and hemodynamic, functional and neurohormonal parameters in patients with heart failure (2001) (6)
Impact of ultra‐thin struts on restenosis after chronic total occlusion recanalization: Insights from the randomized PRISON IV trial (2018) (6)
Value of C-reactive protein in patients with stable angina pectoris, coronary narrowing (30% to 70%), and normal fractional flow reserve. (2003) (6)
Short versus conventional hydration for prevention of kidney injury during pre-TAVI computed tomography angiography (2018) (6)
Scaffold thrombosis following implantation of the ABSORB BVS in routine clinical practice: Insight into possible mechanisms from optical coherence tomography (2018) (5)
Effect of a Web-based Health Risk Assessment with Tailored Feedback on Lifestyle among Voluntary Participating Employees: A Long-term Followup Study (2013) (5)
Long-term comparison of sirolimus-eluting and bare-metal stents in ST-segment elevation myocardial infarction (2014) (5)
Thrombospondin gene polymorphisms and the risk of angiographic coronary in-stent restenosis. (2004) (5)
Angiographic and clinical outcomes of antegrade versus retrograde techniques for chronic total occlusion revascularizations: Insights from the PRISON IV trial (2018) (5)
Challenges in the adjudication of major bleeding events in acute coronary syndrome: a plea for a standardized approach and guidance to adjudication. (2016) (5)
Patients with a normal exercise thallium-201 myocardial scintigram : always a good prognosis? (1993) (5)
Coronary stenting with the Genous™ Bio-Engineered R Stent™ in elderly patients. (2011) (5)
Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019 (2020) (5)
782-1 Excimer Laser Coronary Angioplasty Versus Balloon Angioplasty Used in Long Coronary Lesions: The Longterm Results of the AMRO-Trial (1995) (5)
External Validation of the ELAN‐HF Score, Predicting 6‐Month All‐Cause Mortality in Patients Hospitalized for Acute Decompensated Heart Failure (2019) (5)
A comparative analysis of three widely used lipid management guidelines in the EPIC-Norfolk cohort (2013) (5)
Median Nerve Conduction Velocity and Central Conduction Time Measured With Somatosensory Evoked Potentials in Thyroxine-Treated Infants With Down Syndrome (2006) (5)
Rivaroxaban after transcatheter aortic valve replacement: the GALILEO trial. (2020) (5)
Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials. (2017) (5)
The relationship of pre-procedural Dmax based sizing to lesion level outcomes in Absorb BVS and Xience EES treated patients in the AIDA trial (2019) (5)
Impact of Chronic Total Occlusion Location on LV Function in ST-Segment Elevation Myocardial Infarction Patients. (2017) (5)
One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study. (2017) (4)
Atrial septal defect in adults is associated with airway hyperresponsiveness (2018) (4)
The biochemical aspects of a non-ST-segment elevation acute coronary syndrome. (2012) (4)
Clinical outcomes after bare‐metal stenting in diabetic patients with lesions carrying a low risk of restenosis (2013) (4)
Experiences with the Absorb everolimus-eluting bioresorbable vascular scaffold in all comers: The St. Antonius hospital single centre registry (2015) (4)
Evaluation of the long-term functional outcome assessed by myocardial perfusion scintigraphy following excimer laser angioplasty compared to balloon angioplasty in longer coronary lesions (2004) (4)
Prognostic implications of resting distal coronary-to-aortic pressure ratio compared with fractional flow reserve: a 10-year follow-up study after deferral of revascularisation (2020) (4)
RETRANSFUSION OF PERICARDIAL BLOOD DOES NOT TRIGGER SYSTEMIC COAGULATION DURING CARDIOPULMONARY BYPASS (2007) (4)
Survival of patients after ST-elevation myocardial infarction: external validation of a predictive biomarker model. (2012) (4)
Pre-hospital management, procedural performance and outcomes for primary percutaneous coronary intervention in ST-elevation myocardial infarction in the Netherlands: Insights from the Dutch cohort of the APPOSITION-III trial (2016) (4)
[11-year survival following aortocoronary bypass surgery]. (1991) (4)
Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent. (2017) (4)
TCT-20 Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) in Acute ST-segment Elevation Myocardial Infarction: Final Results of the Prepare RAMSES Study (2014) (4)
Long‐term follow‐up after nonurgent percutaneous coronary intervention in unprotected left main coronary arteries (2010) (4)
Does acute coronary syndrome impact on the incidence of thrombosis after the implantation of an Absorb bioresorbable vascular scaffold? (2017) (4)
Efficacy and safety of the GOLD FORCE multicentre randomized clinical trial: multielectrode phased radiofrequency vs. irrigated radiofrequency single-tip catheter with contact force ablation for treatment of symptomatic paroxysmal atrial fibrillation. (2021) (4)
Exclusion of Acute Myocardial Infarction. The Value of Measuring Creatine Kinase Slope (1995) (4)
Timing of intervention in patients undergoing invasive management for acute coronary syndromes. (2010) (4)
Oral administration of glycine in the prevention of restenosis after coronary angioplasty. A double blind placebo controlled randomized feasibility trial evaluating safety and efficacy of glycine in the prevention of restenosis after angioplasty (2006) (4)
A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial. (2020) (4)
Cost-effectiveness of intracoronary flow velocity measurements and myocardial perfusion scintigraphy for management of intermediate coronary lesions. (2005) (4)
Long-Term Clinical Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents: Final 5-Year Results of the AIDA Randomized Clinical Trial. (2021) (3)
Fractional Flow Reserve , Absolute and Relative Coronary Blood Flow Velocity Reserve in Relation to the Results of Technetium-99 m Sestambi Single-Photon Emission Computed Tomography in Patients With Two-Vessel Coronary Artery Disease (2016) (3)
Monday, 27 August 2012 (2012) (3)
1-Year outcomes with COMBO stents in small vessel coronary disease: Subgroup analysis from the COMBO collaboration. (2020) (3)
What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. (2017) (3)
Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction. (2011) (3)
[Predictive characteristics for early mortality in patients on the waiting list for aortocoronary bypass surgery]. (1989) (3)
A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial. (2019) (3)
TCT-8 First results of the EXPLORE trial, a Global, Randomized, Prospective, Multicenter Trial Investigating the Impact of Recanalization of a Chronic Total Occlusion on Left Ventricular Function in Patients after Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarctio (2015) (3)
ROUTINE INVASIVE VERSUS SELECTIVE INVASIVE STRATEGY AND LONG-TERM OUTCOMES IN PATIENTS WITH REDUCED RENAL FUNCTION PRESENTING WITH NON-ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME (2012) (3)
Long-term performance of the COMBO dual-therapy stent: Results from the REMEDEE Registry. (2020) (3)
Bursts of reperfusion arrhythmias occur independently of area at risk size and are the first marker of reperfusion injury. (2018) (3)
LONG-TERM CLINICAL OUTCOME OF A REAL WORLD EXPERIENCE IN PATIENTS TREATED WITH A GENOUSTM EPC CAPTURING STENT (2010) (3)
Additional side branch stent placement in patients with long side branch lesions treated with the Tryton dedicated bifurcation side branch stent. (2013) (3)
Early development and the thyroid hormone state in Down syndrome (1999) (3)
Impact of core laboratory assessment on treatment decisions and clinical outcomes using combined fractional flow reserve and coronary flow reserve measurements - DEFINE-FLOW core laboratory sub-study. (2023) (3)
Randomized Multi-center Trial Investigating the Angiographic Outcome of Hybrid Sirolimus-eluting Stents with Biodegradable Polymer Against Everolimus-eluting Stents with Durable Polymer in Chronic Total Occlusions (PRISON IV) (2016) (3)
Monday, 27 August 2012 (2012) (3)
Does the novel delivery system for the STENTYS self-apposing coronary stent increase the risk of stent edge dissections? Optical coherence tomography post stent findings (2018) (3)
Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy (2020) (3)
Sex differences in 1‐year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration (2020) (3)
Inhibition of the tissue factor pathway of coagulation by recombinant nematode anticoagulant protein c2 during elective coronary stent implantation. (2004) (2)
Beta blockers in heart failure haemodynamics, clinical effects and modes of action. (2001) (2)
TCT-79 Chronic Total Occlusions in Sweden – Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) (2012) (2)
One-year clinical outcome after treatment of bare-metal stent in-stent restenosis with the paclitaxel-eluting stent in an unselected cohort. (2010) (2)
782-2 Longterm Outcome of Excimer Laser Angioplasty Versus Balloon Angioplasty in Functional and Total Coronary Occlusions (1995) (2)
Patient, lesion, and procedural variable as risk factors for luminal (1993) (2)
817 The SURF-Trial Pre-Assessment Cohort: A Multivariable Model Accurately Predicts Neoplastic Progression in Barrett's Esophagus Patients With Low-Grade Dysplasia (2015) (2)
TCT-634 Diagnostic accuracy of basal stenosis resistance index (BSR) is higher than that of instantaneous wave-free ratio (iFR): validation of basal stenosis resistance index in an independent cohort of simultaneous pressure and flow measurements (2013) (2)
Myeloperoxidase is not associated with scintigraphic myocardial perfusion abnormalities in type 2 diabetic patients with mild stable anginal complaints. (2011) (2)
Optimized stent implantation according to intracoronary Doppler-derived parameters. (2002) (2)
MYOCARDIAL PERFUSION AFTER INTRACORONARY INFUSION OF MONONUCLEAR CELLS OF BONE MARROW OR PERIPHERAL BLOOD AFTER ACUTE MYOCARDIAL INFARCTION (2010) (2)
Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent (2020) (2)
1-Year Clinical Performance of COMBO Stent Versus Xience Stent in All-Comers Patients With Coronary Artery Disease. (2018) (2)
TCT-387 Collateral quality decay several days after primary PCI: a novel observation from the EXPLORE trial. (2017) (2)
Intracoronary infusion of mononuclear cells from the bone marrow or peripheral blood on the recovery of microvascular function in acute myocardial infarction patients: HEBE Doppler substudy (2009) (2)
Importance of side effects of antiarrhythmic drugs to failure of rhythm control in the RACE study (2003) (2)
Impact of atrial septal defect closure on diffusing capacity for nitric oxide and carbon monoxide (2019) (2)
Rate control in atrial fibrillation, insight into the RACE II study (2013) (2)
Striking the Balance Between Benefits and Costs of Ticagrelor Beyond 1 Year After Myocardial Infarction. (2017) (2)
1021 Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction (2008) (2)
Admission Lipoprotein-Associated Phospholipase A2 Activity Is Not Associated with Long-Term Clinical Outcomes after ST-Segment Elevation Myocardial Infarction (2014) (2)
Impact of Intracoronary Cell Therapy on Left Ventricular Function in the Setting of Acute Myocardial Infarction, A Collaborative Meta-analysis of Randomized Controlled Clinical Trials (2012) (2)
2035Mid- and long-term outcome of the EXPLORE trial: investigating the impact of CTO PCI versus no-CTO PCI in STEMI patients with a concurrent CTO (2017) (2)
One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration (2021) (2)
Left ventricular thrombus following primary percutaneous coronary intervention as assessed by cardiac magnetic resonance imaging in acute myocardial infarction (2010) (2)
Abstract 18332: Clinical Parameters Associated with the Development of the Coronary Collateral Circulation in Patients with a Chronic Total Occlusion (2012) (2)
TCT-719 Clinical Outcomes after Transcatheter Aortic Valve Implantation Under Local Analgesia (2013) (2)
All allusions to the great war aside... (2002) (2)
Supraventricular tachyarrhythmias early after coronary artery bypass graft surgery: Analysis of risk factors (1991) (2)
Two‐year clinical outcomes after successful transcatheter aortic valve implantation with balloon‐expandable versus self‐expanding valves: A subanalysis of the GALILEO trial (2022) (2)
Rationale and Design of the ISOLATION Study: A Multicenter Prospective Cohort Study Identifying Predictors for Successful Atrial Fibrillation Ablation in an Integrated Clinical Care and Research Pathway (2022) (2)
Unstable angina pectoris (1987) (2)
Vitamin D deficiency is not associated with thyroid autoimmunity (2012) (1)
Su1965 Digital Microscopy Is a Valid Alternative to Conventional Microscopy for Diagnosing Barrett's Esophagus (2015) (1)
[Long-term treatment with calcium antagonists: advantageous effects and risks]. (1995) (1)
Microvascular resistance in addition to stenosis resistance best predicts inducible myocardial ischemia (2003) (1)
Choice of Optimal Strategies To Diagnose Coronary-artery Disease in Women (1983) (1)
TREATMENT, OBSERVATIONS, AND OUTCOME EVENTS (1987) (1)
Outcomes of bioresorbable vascular scaffolds versus everolimus-eluting stents by coronary complexity: a sub-analysis of the AIDA trial (2020) (1)
TCT-234 3-Year Clinical Outcome of the PRISON-IV Trial: Ultra-Thin Struts Versus Conventional Drug Eluting Stents in Total Coronary Occlusions (2019) (1)
Article referred to: Colchicine and risk of non-cardiovascular death in patients with coronary artery disease: a pooled analysis underlying possible safety concerns. (2021) (1)
Sa1962 DUODENAL MUCOSAL RESURFACING (DMR) COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT WHILE MAINTAINING GLYCAEMIC CONTROL AND IMPROVING OVERALL METABOLIC HEALTH IN TYPE 2 DIABETES (2019) (1)
IMPROVEMENT OF RISK FACTOR CONTROL AFTER AN ACUTE CORONARY SYNDROME BY A NURSE COORDINATED PREVENTION PROGRAM: RESULTS FROM A RANDOMIZED TRIAL (2011) (1)
The influence of implantation techniques on lesion oriented-outcomes in Absorb BVS and Xience EES lesions treated in routine clinical practice at complete three year follow-up: AIDA trial QCA substudy (2020) (1)
Short term mortality in patients selected for coronary artery bypass surgery: A case-control study (1990) (1)
327infective endocarditis after Melody valve implantation in the pulmonary position: a meta-analysis (2017) (1)
Platelet antiaggregants in secondary prevention after stroke: Does dipyridamole add to the effect of aspirin? (1993) (1)
The additional value of C-reactive protein in patients with intermediate coronary lesions and a normal fractional flow reserve (2003) (1)
Analysis of Differences in Assessment of Left Ventricular Function on Echocardiography and Nuclear Perfusion Imaging. (2021) (1)
Heart Rate Variabilit From 24‐Hour Electrocardiography and the 2‐Year Risk for Sudden Death (1993) (1)
TCT-13 Final 2-year Results of the APPOSITION III Study Evaluating the Use of the STENTYS Self-apposing Stent for the Treatment of ST-segment Elevation Myocardial Infarction in the Setting of Primary PCI (2014) (1)
15P Patient randomization and medication distribution independent of the pharmaceutical sponsor (1994) (1)
Vasectomy and cholesterol. (1981) (1)
Ventricular arrhythmia bursts following primary percutaneous coronary intervention for acute myocardial infarction: correlations with microvascular obstruction and final infarct size using CMR (2013) (1)
The Course of Left Ventricular Thrombus Formation following Primary Percutaneous Coronary Intervention as Assessed by Cardiac Magnetic Resonance Imaging in Acute Myocardial Infarction (2010) (1)
The effect of repeated ischaemic periods on left ventricular dynamics during percutaneous coronary intervention. (2010) (1)
Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score. (2019) (1)
TCT-440 Two-year Clinical Outcomes Of Primary Stenting Of Totally Occluded Native Coronary Arteries III (PRISON III): A Randomized Comparison Of Sirolimus-Eluting Stent Implantation With Zotarolimus-Eluting Stent Implantation For The Treatment Of Total Coronary Occlusions (2012) (1)
TCT-63 One Year Results Of The REMEDEE Registry: Clinical Outcomes After Deployment Of The Abluminal Sirolimus Coated Bio-Engineerd Stent In A Multicenter, Prospective Post Market Registry (2015) (1)
Final 5-year results of the TRIAS-LR: a multi-centre, randomized trial comparing the Genous endothelial progenitor cell capturing stent with bare metal stents in patients with low risk for restenosis (2020) (1)
P2798Final 5-year outcomes of the TRIAS High Risk of Restenosis; a multi-centre, randomized trial comparing endothelial progenitor cell capturing stent with drug-eluting stents (2019) (1)
DExamethasone for Cardiac Surgery ( DECS ) study group Members of the DECS study group ( The Netherlands ) (2015) (1)
Chapterr 6 Evaluationn of toe pressure and transcutaneous oxygenn measurements in the management of chronic criticall leg ischemia : a diagnostic randomized clinical trial l (2007) (1)
1156-P: Duodenal Mucosal Resurfacing (DMR) Combined with GLP-1 RA May Eliminate Insulin Therapy and Improve Metabolic Health in Type 2 Diabetes (2019) (1)
TCT-616 Quantification of the Functional Status of the Coronary Microvasculature Distal to Coronary Stenoses by Means of the Hyperemic Microvascular Resistance Index Does Not Require Correction for Collateral Flow Contribution (2013) (1)
Rate or rhythm control for persistent atrial fibrillation. (2003) (1)
Stringency of Rate Control in Patients with Atrial Fibrillation and Heart Failure: Data of the Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison between Lenient versus Strict Rate Control II (RACE II) Study (2010) (1)
[The waiting time for heart interventions: trends for percutaneous coronary interventions and cardiothoracic interventions]. (2003) (1)
GENDER DISPARITY IN CORONARY REVASCULARISATION MANAGEMENT IN EUROPE: A REPORT FROM THE EURO HEART SURVEY (2011) (1)
[Monitoring the safety of participants in randomised clinical trials: basis and methods]. (2008) (1)
Abstract 4491: One-Year Clinical Outcome of a Real World Experience in Patients Treated with a GenousTM EPC Capturing Stent (2008) (1)
Interobserver Agreement after Addition of P53 Staining within a Digital Expert Panel for Barrett's Esophagus (2017) (1)
DIAGNOSTIC ACCURACY OF BASAL STENOSIS RESISTANCE INDEX FOR MYOCARDIAL ISCHEMIA IDENTIFIED BY FRACTIONAL FLOW RESERVE AND IMPLICATIONS OF STENOSIS RESISTANCE INDEX DETERMINED AT SUB–MAXIMALLY ELEVATED CORONARY FLOW RATES (2013) (1)
Intracoronary Infusion Of Mononuclear Cells Compared With Standard Therapy After Acute Myocardial Infarction: 2 Year Magnetic Resonance Imaging Results Of The Randomized Controlled Hebe Trial (2012) (1)
Intracoronary infusion of mononuclear cells potentially prevents post-infarct ventricular remodeling in patients with an initial dilated left ventricle: a HEBE substudy (2009) (1)
Abstract 19640: The Course of Left Ventricular Thrombus Formation following Primary Percutaneous Coronary Intervention as Assessed by Cardiac Magnetic Resonance Imaging in Acute Myocardial Infarction (2010) (1)
Tuesday, 28 August 2012 (2012) (1)
Review of other trials (1987) (1)
[Calcium antagonists: safe or unsafe?]. (1996) (1)
Decrease in lipid rich plaque during percutaneous coronary intervention: reality or artefact? An observational study using Near-Infrared Spectroscopy (2017) (1)
Ten-year outcomes of an early invasive or a selective invasive strategy in non-ST-segment elevation acute coronary syndrome patients with and without diabetes mellitus: a subgroup analysis of the ICTUS trial. (2019) (1)
[Value of basic and intensive management of patients with heart failure; results of a randomised controlled clinical trial]. (2008) (1)
Patients With NonST-Segment Elevation Acute Coronary Syndrome Comparison of an Early Invasive Versus Selective Invasive Management in Treatment in Unstable coronary Syndromes) Trial: A Randomized 5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative (2011) (1)
Faecal microbiota transplantation in Ulcerative Colitis: A randomised controlled trial (2015) (1)
Edoxaban in atrial fibrillation with PCI by ACS or stable CAD presentation: a pre-specified analysis of the ENTRUST-AF PCI trial (2020) (0)
Dynamics of intracoronary thrombosis in STEMI and sudden death patients (2012) (0)
The angiographical stenotic flow reserve compared to intracoronary hemodynamic parameters for evaluation of coronary lesion severity (2003) (0)
One‐year clinical outcomes in patients with chronic kidney disease treated with COMBO stents: From the COMBO collaboration (2020) (0)
P4554Impact of the presence of chronic kidney disease on 1-year target lesion failure in patients treated with a dual-therapy stent (2018) (0)
TCT-278 Clinical Outcomes of All-Comer Patients Presenting With Acute Coronary Syndrome Treated With the COMBO Stent: From the MASCOT and REMEDEE Registry (2019) (0)
Rate control efficacy in permanent atrial fibrillation (2019) (0)
Randomized Trial Comparing Same-Day Discharge With Overnight Hospital Stay After Percutaneous Coronary Intervention Results of the Elective PCI in Outpatient Study (EPOS) Interventional Cardiology (2007) (0)
THE PROGNOSTIC VALUE OF THE THROMBOLYSIS IN MYOCARDIAL INFARCTION (TIMI) RISK INDEX AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-ELEVATION MYOCARDIAL INFARCTION AT LONG-TERM FOLLOW-UP (2011) (0)
Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR guided revascularization. Rationale and study design of the prospective randomized FAST III Trial. (2023) (0)
TCT-68 One Year Clinical Outcomes in Patients with Insulin-Treated Diabetes Mellitus and Non-Insulin-Treated Diabetes Mellitus Compared to Non-Diabetics after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in an All-Comers Registry. (2016) (0)
PREDICTION OF DEATH AND CONGESTIVE HEART FAILURE USING MULTIPLE CONCOMITANT ANGIOGRAPHIC BIOCHEMICAL AND ELECTROCARDIOGRAPHIC BIOMARKERS IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2011) (0)
Original Studies Angiographic Assessment of Aortic Regurgitation by Video-Densitometry in the Setting of TAVI: Echocardiographic and Clinical Correlates (2017) (0)
Erratum (1985) (0)
Increased homogeneity and interobserver agreement after addition of p53 staining within a digital expert panel for Barrett's oesophagus (2017) (0)
DIFFERENCES BETWEEN HS-TROP T AND NT-PROBNP AS PREDICTORS FOR CARDIOVASCULAR OUTCOMES IN PATIENTS WITH PERMANENT ATRIAL FIBRILLATION: DATA FROM THE RACE II STUDY (2014) (0)
Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women. (2022) (0)
Reperfusion arrhythmia bursts predict larger infarct size in STEMI patients undergoing primary percutaneous coronary intervention despite optimal epicardial and microvascular flow (2013) (0)
712-3 Predictive Value of Intraoperative Transesophageal Color Doppler Flow Imaging During Mitral Valve Repair (1995) (0)
UvA-DARE ( Digital Academic Repository ) Abnormalities in liver function and coagulation profile following in the Fontan procedure (1999) (0)
TCT-48 Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT (2019) (0)
TCT-412 Prognostic implications of pressure-bounded coronary flow reserve versus flow-derived coronary flow reserve. (2017) (0)
The relationship between the number of preprocedural circulating endothelial progenitor cells and angiographic restenosis following coronary artery stent placement (2011) (0)
Corrigendum to 'Procedural Outcome and Mid-Term Survival of Lower Risk Transfemoral TAVI Patients Treated With The SAPIEN XT or SAPIEN 3 Device' [American Journal of Cardiology (2018) 856-861]. (2018) (0)
Impact of diabetes mellitus on 2-year outcomes of Absorb BVS compared to Xience EES: a pooled analysis of the COMPARE-ABSORB and AIDA trial (2020) (0)
Treatment and outcome of congenital heart disease (2005) (0)
TCT-470 Two Year Clinical Results after Deployment of the Abluminal Sirolimus Coated Bio-Engineered (COMBO) Stent in a Thousand Patient All-Comers Registry. (2016) (0)
[PROPATRIA and safety in clinical trials. Comments on the IGZ-CCMO-VWA-raport]. (2009) (0)
Pericardial effusion following primary percutaneous coronary intervention is associated with the presence of microvascular obstruction (2010) (0)
P483Trends in mortality over time in a real-world TAVI population (2017) (0)
Abstract 3659: The Impact of Multivessel Disease on Long-term Mortality in Patients with ST-elevation Myocardial Infarction is due to the Presence of a Chronic Total Occlusion (2006) (0)
Associations of major bleeding and recurrent myocardial infarction with the incidence and timing of mortality in patients with ST-segment elevation myocardial infarction (2013) (0)
The authors’ reply (2009) (0)
Quantitative and Spatial Relation of Baseline Atherosclerotic Plaque Burden and Subsequent In- Stent Neointimal Proliferation as Determined by Intravascular Ultrasound (2002) (0)
Abstract 14749: Anatomic and Physiologic Determinants of the Area-at-Risk Differentiate in Range of Infarct Size among Patients Undergoing Primary Percutaneous Coronary Intervention (2012) (0)
Baseline electrocardiographic characteristics on the presenting ECG of patients presenting with an unprotected left main coronary artery related acute myocardial infarction (2013) (0)
Designn issues of a diagnostic randomized clinical trial;; the value of toe and transcutaneous oxygen pressuree measurements in the management of critical legg ischemia (2007) (0)
Aorticc stiffness and diameter predict progressivee aortic dilatation in patientss with Marfan syndrome (2007) (0)
AS-3: Immediate ST-Segment Resolution Is Associated with Left Ventricular Function and Infarct Size Measured by Cardiovascular Magnetic Resonance in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention (2009) (0)
Neovascularization in the intracoronary thrombi of patients with ST-segment Elevation Myocardial Infarction (STEMI) (2013) (0)
Nifedipine and metoprolol in suspected unstable angina (1987) (0)
Wednesday, 29 August 2012 (2012) (0)
TREATMENT STRATEGY AND LONG-TERM MORTALITY IN FEMALE PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME; A SUBSTUDY FROM THE ICTUS TRIAL (2010) (0)
INCREASED REFERENCE AND ABSOLUTE CORONARY FLOW RESERVE AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR A FIRST ACUTE ANTERIOR MYOCARDIAL INFARCTION ARE ASSOCIATED WITH SURVIVAL AT 10 YEARS FOLLOW-UP (2011) (0)
TCT-285 Stent Diameter and Clinical Outcomes After PCI: From the COMBO MASCOT and REMEDEE Collaboration (2019) (0)
chapter 4 dynamics in n-terminal pro-brain natriuretic peptide concentration in patients with non – ST-elevation acute coronary syndrome (2011) (0)
after myocardial infarction compared withother routine clinical variables (1987) (0)
Quality of life and hepato-biliary related symptoms before and after endoscopic removal of bile duct stones (BDS): A randomized trial comparing endoscopic balloon dilatation of the biliary sphincter (EBD) and endoscopic sphincterotomy (EST) (1997) (0)
TCT-633 Discordance of Coronary Flow Velocity Reserve With Fractional Flow Reserve Originates From Microvascular Involvement in Coronary Artery Disease (2013) (0)
Principles and methods of intervention research (2018) (0)
HEBE: Multicentre, randomised trial of intracoronary infusion of autologous mononuclear bone blood marrow cells or peripheral mononuclear blood cells after primary PCI (2006) (0)
TCT-457 The use of a dedicated coronary bifurcation stent in patients presenting with myocardial infarction (2012) (0)
controlled trials? Is there a need to control the placebo in placebo (2006) (0)
[The effect of discontinuation of long-term anticoagulant treatment for myocardial infarct in older patients; a double blind study]. (1979) (0)
VENTRICULAR ARRHYTHMIA BURSTS FOLLOWING PRIMARY PCI FOR ACUTE MYOCARDIAL INFARCTION: CORRELATIONS WITH CMRI OF MICROVASCULAR OBSTRUCTION AND FINAL INFARCT SIZE (2013) (0)
126 Oral Structuring a Nurse Led Secondary Prevention Clinic: A Multicenter Experience in 700 Patients (2010) (0)
The Impact of Percutaneous Coronary Intervention on Mortality in Patients With Coronary Lesions Who Underwent Transcatheter Aortic Valve Replacement. (2021) (0)
The Enduring Legacy of Failed Revascularization Trials. (2021) (0)
Becoming a dysplastic Barrett's oesophagus expert : quantification of expertise and continuous structural education in the set-up of a national digital review panel (2019) (0)
BASAL VERSUS HYPEREMIC CONDITIONS FOR PHYSIOLOGICAL STENOSIS SEVERITY ASSESSMENT (2014) (0)
Abstract 4194: Multivessel Primary Percutaneous Coronary Intervention in Patients With Multivessel Disease and ST-Elevation Myocardial Infarction Complicated With Cardiogenic Shock (2009) (0)
Long-term outcome of discordance between fractional flow reserve and coronary flow velocity reserve after deferral of percutaneous coronary intervention using the clinically adopted 0.80 FFR cut-off (2013) (0)
[Early thrombolysis improves the long-term prognosis for patients with a heart infarct]. (1990) (0)
Clinical features for outcome in hypertrophic cardiomyopathy (1991) (0)
SHORT-TERM AND LONG-TERM PROGNOSTIC VALUE OF THE TIMI RISK SCORE AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-ELEVATION MYOCARDIAL INFARCTION (2011) (0)
REFERENCE CORONARY FLOW VELOCITY RESERVE DETERMINED AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR A FIRST ACUTE ANTERIOR MYOCARDIAL INFARCTION IS AN INDEPENDENT PREDICTOR OF CARDIAC MORTALITY AT LONG TERM FOLLOW UP (2012) (0)
UvA-DARE ( Digital Academic Repository ) Coronary Stenting With the Genous ( TM ) Bio-Engineered R Stent ( TM ) in Elderly Patients Damman (2011) (0)
P1664Clinical outcomes by potency of P2Y12 inhibitor following COMBO DTS PCI: From the COMBO collaboration (2018) (0)
Prognostic value of access site and non-access site bleeding in ST-segment elevation myocardial infarction (2013) (0)
TCT-19 Mid- and long-term outcome of the EXPLORE trial, a Global, Randomized, Prospective, Multicenter Trial Investigating the Impact of Recanalization of a Chronic Total Occlusion in Patients after Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction (2017) (0)
MORTALITY IN CONGENITAL HEART DISEASE; ARE GOVERNMENTAL REGISTRIES RELIABLE FOR CAUSE OF DEATH? (2010) (0)
Abstract 3437: Six Months Clinical Outcome in Patients Treated with a Single GenousTM EPC Capturing Stent for Bifurcation Lesions (2007) (0)
Cell therapy in reperfused acute myocardial infarction does not improve the recovery of perfusion in the infarcted myocardium ; a cardiac magnetic resonance imaging study (2016) (0)
Transfemoral TAVR in Nonagenarians (0)
Long-term follow-up after Impella 2.5 support in high-risk percutaneous coronary intervention: results from the Europella registry (2012) (0)
TCT-18 Long-term Outcome Of Discordance Between Fractional Flow Reserve And Coronary Flow Velocity Reserve After Deferral Of Percutaneous Coronary Intervention (2012) (0)
TCT-427 Three Year Clinical Performance of the Dual-therapy COMBO stent: Insights from the REMEDEE Registry (2017) (0)
P2695ABSORB bioresorbable scaffold versus Xience metallic stent in acute coronary syndromes with treated with percutaneous coronary intervention. A subanalysis of the COMPARE-ABSORB trial (2019) (0)
FORMATION OF THE HINT COHORT (1987) (0)
[Early invasive strategy no better than a selective invasive strategy for patients with non-ST-segment elevation acute coronary syndromes and elevated cardiac troponin T levels: long-term follow-up results of the ICTUS trial]. (2008) (0)
UvA-DARE ( Digital Academic Repository ) Early invasive versus selectively invasive management for acute coronary syndromes (2005) (0)
RELATIONSHIP BETWEEN RENAL FUNCTION, ANTICOAGULATION LEVELS AND CLINICAL OUTCOME IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION AND UNFRACTIONATED HEPARIN (2010) (0)
Mo1108 Cost-Effectiveness Analysis of Radiofrequency Ablation for Barrett's Esophagus With Low-Grade Dysplasia: Results From a Randomized Controlled Trial (SURF) (2014) (0)
ISCHEMIA GRADING IN STEMI PATIENTS UNDERGOING PCI AND ITS CORRELATION WITH LONG-TERM CLINICAL OUTCOME (2013) (0)
Predictors of six-month clinical outcome after balloon angloplasty to guide provisional stent implantation (2002) (0)
Aortic elasticity of the Marfan aorta Comparison between patients with and without aortic root replacement (2002) (0)
CRT-312 Stent Optimization Following Music Criteria Comparing Optical Coherence Tomography vs Intravascular Ultrasound: The OCTIVUS Study (2014) (0)
P2808Absorb bioresorbable scaffold vs. Xience metallic stent: outcomes in the AIDA trial stratified by SYNTAX score (2019) (0)
Abstract 3671: Myocardial Perfusion Scintigraphy versus Intracoronary Flow Velocity Reserve in Multivessel Coronary Artery Disease: Long Term Clinical Follow-up (2006) (0)
AS-46: Randomized Comparison of Primary Percutaneous Coronary Intervention with Combined Proximal Embolic Protection and Thrombus Aspiration versus Primary Percutaneous Coronary Intervention Alone in ST-segment Elevation Myocardial Infarction (2009) (0)
Time from coronary artery bypass surgery does not affect outcome in patients treated with primary angioplasty for acute saphenous vein graft occlusion (2007) (0)
CONSISTENT EFFICACY OF COLCHICINE OVER TIME IN PATIENTS WITH RECENT VERSUS REMOTE PRIOR ACUTE CORONARY SYNDROME - A LODOCO2 SUBSTUDY (2021) (0)
Becoming an Expert in Dysplastic Barrett's Esophagus Assessment : Quantification of Expertise and Continuous Structural Education in the Set-Up of a National Digital Histopathology Review Panel (2019) (0)
TCT-796 A paradox in sex-specific clinical outcomes after bioresorbable scaffold implantation: 2-year results from the AIDA trial (2018) (0)
P4683Feature-tracking cardiovascular magnetic resonance derived myocardial right ventricular strain parameters in patients with ST-segment elevation myocardial infarction patients and a concurrent CTO (2018) (0)
[National guidelines for clinical decisions, a methodological view]. (1998) (0)
TCT-621 ABSORB Everolimus-Eluting Bioresorbable Scaffold In Coronary Interventions: 12-Months Results Of a Single Center Registry (2014) (0)
Moderated PosterCOMBO Stent StudiesTCT-429 Comparison of the clinical performance between COMBO and Xience stent at one year follow-up in all-comers patients (2017) (0)
A multiple biomarker risk score predicts long-term mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction (2013) (0)
Predictors of Restenosis Within the Coronary Wallstent (2005) (0)
intermediate coronary narrowings and multivessel disease Prognostic value of coronary blood flow velocity and myocardial perfusion in (2011) (0)
Abstract 5470: Coronary Plaque Inflammation as a Predictor for Death at Long Term Follow Up (2008) (0)
Limitations of 2-D echocardiography to detect mural thrombus after ST-elevation acute myocardial infarction (2010) (0)
More pronounced diastolic left ventricular dysfunction in patients with accelerated idioventricular rhythm after reperfusion by primary angioplasty (2009) (0)
P2775Twelve year experiences with left ventricular circulatory support with Impella (2017) (0)
Sudden cardiac death in patients with persistent atrial fibrillation. Results of the RACE study (2003) (0)
Abstract P195: Acute Hemodynamic Effects of Accelerated Idioventricular Rhythm in Primary Percutaneous Coronary Intervention (2008) (0)
TCT-586 Long-term performance of the Dual-therapy COMBO stent: results from the REMEDEE Registry (2018) (0)
CORONARY ARTERY DISEASE Twelve-month Outcomes After Coronary Stenting (2011) (0)
Abstract 3050: Safety and Feasibility of Elective High-Risk Percutaneous Coronary Intervention Procedures with Left Ventricular Support of the Impella Recover LP 2.5 device (2006) (0)
The prognostic value of stenosis resistance index after deferral of percutaneous transluminal coronary angioplasty in intermediate coronary lesions showing discordant results between fractional and coronary blood flow velocity reserve (2003) (0)
TCT-347 The impact of post-dilatation on stent expansion and eccentricity using the novel balloon delivery system for the self-apposing coronary artery stent; a detailed Optical Coherence Tomography analysis (2015) (0)
P4677Segmental strain predicts functional recovery incremental to infarct in patients with a concurrent chronic total occlusion after primary percutaneous coronary intervention for STEMI (2018) (0)
Sa1939 DUODENAL MUCOSAL RESURFACING COMBINED WITH GLP-1 RECEPTOR AGONISM MAY ELIMINATE INSULIN TREATMENT IN TYPE 2 DIABETES WHILE IMPROVING GLYCEMIC CONTROL AND OVERALL METABOLIC HEALTH (2020) (0)
Low molecular weight heparin as an adjunct to thrombolysis for acute myocardial infarction: the FATIMA study. Fraxiparin Anticoagulant Therapy In Myocardial infarction study (1998) (0)
18 F-fluoride positron emission tomography imaging of Penile Arteries and Erectile Dysfunction A brief title; Penile Fluoride uptake & Erectile Dysfunction. (2018) (0)
Clinical decision making in elderly with aortic stenosis (2007) (0)
TCT@ACC–i2: Invasive and Interventional Cardiology ADDITIONAL SIDE BRANCH STENT PLACEMENT IN PATIENTS WITH LONG SIDE BRANCH LESIONS TREATED WITH A DEDICATED TRYTON SIDE BRANCH STENT (2013) (0)
LONG-TERM MORTALITY IN INSULIN DEPENDENT VERSUS NON-INSULIN DEPENDENT DIABETIC ST ELEVATION MYOCARDIAL INFARCTION PATIENTS AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION (2010) (0)
TCT-430 ABSORB everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in daily clinical practice. A single center registry analysis (2013) (0)
Abstract 16711: Timing of Angiography in Non-ST-elevation Acute Coronary Syndromes and the Effect on Cardiovascular Mortality and Myocardial Infarction. (2010) (0)
FRACTIONAL FLOW RESERVE IS UNLIKELY TO BE ABNORMAL IN THE PRESENCE OF HIGH MICROVASCULAR RESISTANCE (2014) (0)
The ILIAS study (Intermediate Lesions: Intracoronary flow Assessment versus Tc-99m-MIBI SPECT): a Dutch multicentre trial (2000) (0)
The Influence of Implantation Techniques on Lesion-Oriented Outcomes in Absorb BVS and Xience EES Lesions Treated in Routine Clinical Practice at Complete Three-Year Follow-Up - AIDA Trial QCA Substudy (2021) (0)
TCT-718 Transfemoral Transcatheter Aortic Valve Implantation with the Edwards Sapien Versus the Medtronic CoreValve Device (2013) (0)
Confoundedness of the odds ratio in randomized clinical trials (1986) (0)
TCT-179 The Influence of Increasing Stent Length on Outcomes in Absorb BVS or Xience EES-Treated Patients in Routine Clinical PCI Practice: AIDA Trial Substudy (2019) (0)
Effective predischarge triage at the emergency room with dobutamine stress echocardiography and cardiac troponin T (2002) (0)
Conservative, True Selective Invasive, and Routine Invasive Strategies in Non-ST-Segment Elevation Acute Coronary Syndromes Reply (2010) (0)
TCT-592 Lower Five Year Event Rates In The Genous Endothelial Progenitor Cell Capturing Stent Compared With A Drug Eluting Stent In De-novo Coronary Artery Lesions With A High-risk Of Restenosis; A Randomized Controlled Trial (2014) (0)
P1661Evaluation of transradial versus transfemoral procedures in all-comers patients treated with the dual-therapy stent (2018) (0)
0.754), compared with a standard DAPT regimen (12-month DAPT followed by 12-month aspirin monotherapy). (2019) (0)
Planning and conduct (1987) (0)
Procedural radiation exposure of interventional cardiologists and radiologists (0)
The Effect Of Acute Coronary Syndrome Compared To Stable Angina On The Relationship Between Intravascular Ultrasound Minimal Luminal Area And Fractional Flow Reserve (2016) (0)
SUBJECTS AND METHODS SUBJECTS (2018) (0)
Abstract 4510: Long-term Clinical Outcomes of an Early Invasive Strategy Compared With a Conservative Strategy for Non-ST-Elevation Acute Coronary Syndromes: A Collaborative Analysis of Individual Patient Data From the FRISC-II, ICTUS, RITA-3 Trials (2009) (0)
Nifedipine and metoprolol in suspected unstable angina. Treatment, observations, and outcome events. (1987) (0)
AGE AND ONE-YEAR MORTALITY AFTER ST ELEVATION MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS INTERVENTION (2010) (0)
Abstract 4333: Heterogeneity in Revascularization in Non-ST-elevation Acute Coronary Syndromes and the Effect on Long-term Clinical Outcomes Mortality and Myocardial Infarction: A Collaborative Analysis of Individual Patient Data From the FRISC-II, ICTUS, RITA-3 Trials (2009) (0)
Abstract 19050: Does Type of Culprit Lesion Matter in Patients with Acute Coronary Syndrome and Prior Coronary Artery Bypass Graft Surgery Undergoing Percutaneous Coronary Intervention? (2012) (0)
Atrial Right-to-Left Shunting Does Not Predict PFO Orifice Area in Patients Undergoing Percutaneous PFO Closure. (2022) (0)
UvA-DARE ( Digital Academic Repository ) PCI of complex coronary lesions , new stent technologies , and clinical outcomes (2011) (0)
Abstract 16757: Admission Lipoprotein-Associated Phospholipase A2 Activity does not Predict Long-Term Mortality in ST-Segment Elevation Myocardial Infarction (2012) (0)
Progress monitoring and termination (1987) (0)
Abstract 5582: Impact of a Concurrent Chronic Total Occlusion on Long-term Mortality in Hospital Survivors after ST Elevation Myocardial Infarction (2008) (0)
PROGNOSTIC VALUE OF FRACTIONAL FFOW RESERVE AFTER DEFERRAL OF REVASCULARIZATION USING THE 0.75 DEFER OR 0.80 FAME FRACTIONAL FLOW RESERVE CUT-OFF VALUE: CLINICAL IMPLICATIONS OF THE 0.75 – 0.80 FRACTIONAL FLOW RESERVE GREY ZONE. (2014) (0)
[Benefit and risks of prolonged continued anticoagulant treatment in patients who have experienced a transmural heart infarct]. (1983) (0)
Acute Coronary Syndromes Rebound Thrombin Generation After Heparin Therapy in Unstable Angina A Randomized Comparison Between Unfractionated and Low-Molecular-Weight Heparin (2016) (0)
Abstract 2000: Incomplete ST-Segment Deviation Resolution after Primary Percutaneous Coronary Intervention in Patients with Multivessel Disease is Mainly Due to the Presence of a Non-Infarct-Related Chronic Total Occlusion (2008) (0)
A NORMAL RELATIVE CORONARY FLOW RESERVE IS ASSOCIATED WITH A LOWER MORTALITY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE. (2010) (0)
Compariso nn of aorti c elasticit y in patient s wit hh the Marfan syndrom e wit h and withou t aorti cc root replacemen t (2007) (0)
TCT-6 The CENTER-Collaboration: Outcomes in patients undergoing transfemoral transcatheter aortic valve implantation with balloon-expandable valves versus self-expandable valves. (2018) (0)
The favourable safety profile of the Impella percutaneous left ventricular assist device with regard to cerebrovascular complications (2012) (0)
Abstract 12549: Early Post-Discharge Changes in NT-ProBNP Levels as Risk Stratification After Heart Failure Hospitalization (2011) (0)
Endoscopic resection of early esophageal adenocarcinoma : significant variation in clinical management caused by discrepancies in histological interpretation; recommendations to improve concordance (2019) (0)
TCT-164 Clinical Outcomes at 3 Years of the Absorb Bioresorbable Vascular Scaffold Versus Xience Drug-Eluting Metallic Stent in Patients With or Without Acute Coronary Syndrome: AIDA Trial Substudy (2019) (0)
1095-199 Disparity between dobutamine stress and physical exercise magnetic resonance imaging in patients with an intra-atrial correction for transposition of the great arteries (2004) (0)
More Confidence Intervals and Fewer p Values: A Positive Trend? (2021) (0)
Minimal microvascular resistance is associated with the extent of epicardial stenosis severity and is significantly associated with the presence of reversible myocardial ischemia (2013) (0)
500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study. (2019) (0)
[Fundamentals of intervention research]. (1988) (0)
INTER-CORE LAB VARIABILITY IN ANALYZING QUANTITATIVE CORONARY ANGIOGRAPHY FOR BIFURCATION LESIONS: A POST-HOC ANALYSIS OF A RANDOMIZED TRIAL (2015) (0)
TCT-745 Insights Into Sex Differences in Transfemoral Transcatheter Aortic Valve Implantation From 2007–2018: From the CENTER Collaboration, A Global Patient-Level Analysis of 12,381 Patients (2019) (0)
IMPACT OF GEOGRAPHICAL VARIATION BETWEEN EUROPE AND ASIA ON CLINICAL OUTCOMES IN PATIENTS WITH HIGH BLEEDING RISK (HBR) AND BIODEGRADABLE-POLYMER SIROLIMUSELUTING CORONARY STENT: A SUBSTUDY OF MASTER DAPT (2023) (0)
Nifedipine and metoprolol in suspected unstable angina. Unstable angina pectoris. (1987) (0)
All allusions to the Great War aside ... : letter (2002) (0)
TCT-47 Angiographic And Procedural Outcome Of Percutaneous Coronary Intervention With The STENTYS(r) Self-Apposing Coronary Stent In Patients Not Treated For STEMI. (2013) (0)
Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study (2020) (0)
Abstract 4679: Impact of a Chronic Total Occlusion in a Non-Infarct Related Artery on Long-Term Mortality in Patients With Diabetes Mellitus After ST Elevation Myocardial Infarction (2009) (0)
Acute coronary syndromes. (2009) (0)
TCT-439 Increased incidence of revascularization in diabetic patients treated with the ABSORB everolimus-eluting bioresorbable scaffold: 24-months clinical results. (2016) (0)
13.53 Comparison of different diagnostic strategies in patients with multivessel coronary artery disease: the “ILIAS” study (2001) (0)
Abstract 14862: Prediction of Myocardial Infarct Size Using Multiple Concomitant Angiographic, Biochemical and Electrocardiographic Biomarkers in Patients with ST-Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention (2011) (0)
1115-75 Prognostic impact of depression following myocardial infarction: A meta-analysis (2004) (0)
TCT-515 Prognostic implications of instantaneous wave-free ratio (iFR) and resting distal-to-aortic pressure ratio (Pd/Pa) compared with fractional flow reserve (FFR). A 10-year follow-up study after deferral of revascularization. (2016) (0)
A simple ECG abnormality coding device applicable in multicenter trials (1984) (0)
Long-term Angiographic Outcome (2005) (0)
CRT-311 The Octivus Study (Optical Coherence Tomography vs Intravascular Ultrasound): Evaluation of Observer Variability and Reliability in the Assessment of Stent Deployment (2014) (0)
P1675Futility of tavi according to clinical and patient-reported outcomes (2018) (0)
[Consensus antithrombotic prophylaxis of vascular incidents in patients with manifest atherosclerotic vascular diseases. Central Guidance Organization for Peer Review]. (1998) (0)
Long-Term Anticoagulant Therapy After Myocardial Infarction in the Elderly Patient (1979) (0)
Toll-like-receptor 4 (TLR4) polymorphisms show no association with the risk of clinical restenosis after elective PCI (2006) (0)
Management of acute coronary syndromes - Reply (2005) (0)
TCT-399 The Impact Of STENTYS® (STENTYS SA, Paris, France) Self-Apposing Coronary Artery Stent Placement On The Lipid Core Plaque Burden, As Assessed With Near-Infrared Spectroscopy; How Does The Lipid Rich Plaque Modify After Stent Deployment And After Balloon Post-Dilatation? (2014) (0)
The ILIAS study (Intermediate Lesions (2000) (0)
Sa1249 Histological Assessment of Barrett's Esophagus by an Expert Panel of Gastrointestinal Pathologists Is Associated With Substantial Interobserver Agreement (2016) (0)
Cardiovascular Risk and Known Coronary Artery Disease Are Associated With Colorectal Adenoma and Advanced Neoplasia (0)
CLINICAL OUTCOMES AT 2 YEARS OF THE ABSORB BIORESORBABLE VASCULAR SCAFFOLD VERSUS THE XIENCE DRUG-ELUTING METALLIC STENT IN PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME VERSUS STABLE CORONARY DISEASE: AIDA TRIAL SUB-STUDY (2019) (0)
Clinical pharmacological meeting (1984) (0)
ACTION-1: study protocol for a randomised controlled trial on ACT-guided heparinization during open abdominal aortic aneurysm repair (2021) (0)
TCT-124 Distal Embolization of Hydrophilic Coating Material from Coronary Guide Wires after Percutaneous Coronary Interventions (2014) (0)
Four-year results of the AIDA trial: comparison of Absorb bioresorbable scaffold with Xience everolimus-eluting metallic stent in daily clinical practice (2020) (0)
18F-FLOURIDE UPTAKE IN PENILE ARTERIES: DOES IT REPRESENT ATHEROSCLEROTIC BASIS OF ERECTILE DYSFUNCTION IN PATIENTS WITH PROSTATE CANCER (2019) (0)
TCT-527 Coronary guide wires: a source of foreign material emboli? Scanning electron microscopy analysis of coronary guidewires (2017) (0)
TCT-71 Predictors, incidence and outcomes of patients undergoing transcatheter aortic valve implantation complicated by stroke – From the CENTER-Collaboration (2018) (0)
Influence of medical intervention on sympathetic activity in heart failure (2007) (0)
TCT-38 Long-term Clinical Outcome Of Resting Pd/Pa Versus FFR-guided Deferral Of Revascularization (2015) (0)
Estimation of treatment effect in the presence of chance incomparability at baseline: A detailed example (1986) (0)
126Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy (2019) (0)
TCT-148 10-Year Clinical Outcomes of an Early Invasive Versus a Selective Strategy in Patients Non-ST-segment Elevation Acute Coronary Syndrome With Diabetes Mellitus: A Subgroup Analysis of the ICTUS Trial (2017) (0)
MULTIVESSEL VERSUS CULPRIT-ONLY PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MULTIVESSEL DISEASE AND ST-ELEVATION MYOCARDIAL INFARCTION COMPLICATED WITH CARDIOGENIC SHOCK (2010) (0)
IMPACT OF MULTIVESSEL DISEASE WITH AND WITHOUT A CONCURRENT CHRONIC TOTAL OCCLUSION ON SHORT AND LONG-TERM MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH AND WITHOUT CARDIOGENIC SHOCK (2011) (0)
TCT-166 Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial (2019) (0)
The prognostic value of new cardio-biochemical markers in patients with unstable angina (1995) (0)
Response to Letters Regarding Article, “Presence of Older Thrombus Is an Independent Predictor of Long-Term Mortality in Patients With ST-Elevation Myocardial Infarction Treated With Thrombus Aspiration During Primary Percutaneous Coronary Intervention” (2009) (0)
GASTROINTESTINAL BLEEDING IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jann G. P. Tijssen?

Jann G. P. Tijssen is affiliated with the following schools:

University of Amsterdam